EDMA
3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the methamphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release.
Wikipage disambiguates
3,4-EDMA3,4-Ethylenedioxy-N-methamphetamine3,4-Ethylenedioxy-N-methylamphetamine3,4-Ethylenedioxymethamphetamine3,4-Ethylenedioxymethylamphetamine3,4-ethylenedioxy-N-methamphetamine3,4-ethylenedioxy-N-methylamphetamine3,4-ethylenedioxymethamphetamine3,4-ethylenedioxymethylamphetamineEthylenedioxymethamphetamineEthylenedioxymethylamphetamine
Wikipage redirect
3,4-EDMA3,4-Ethylenedioxy-N-methamphetamine3,4-Ethylenedioxy-N-methylamphetamine3,4-Ethylenedioxymethamphetamine3,4-Ethylenedioxymethylamphetamine3,4-Ethylidenedioxyamphetamine3,4-ethylenedioxy-N-methamphetamine3,4-ethylenedioxy-N-methylamphetamine3,4-ethylenedioxymethamphetamine3,4-ethylenedioxymethylamphetamine6-APTC12H17NO2EDMA (disambiguation)EthylenedioxyEthylenedioxymethamphetamineEthylenedioxymethylamphetamineList of designer drugsList of psychedelic drugsMDMAMDMC (disambiguation)Serotonin releasing agentSubstituted amphetamineSubstituted methylenedioxyphenethylamineTH-PVP
Link from a Wikipage to another Wikipage
primaryTopic
EDMA
3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the methamphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release.
has abstract
3,4-Ethylenedioxy-N-methylamph ...... e effects on dopamine release.
@en
エチレンジオキシメタンフェタミン (3,4-Ethylene ...... 基づいており、より大量の投与ではより作用が強い可能性がある。
@ja
CAS number
133787-66-3
PubChem
Link from a Wikipage to an external page
Wikipage page ID
10,115,053
page length (characters) of wiki page
Wikipage revision ID
992,135,938
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
23,553,090
IUPAC name
legal CA
Schedule III
@en
legal DE
NpSG
@en
legal UK
Class B
@en
PubChem
24,257,269
routes of administration
SMILES
CCNC
@en
StdInChIKey
UJKWLAZYSLJTKA-UHFFFAOYSA-N
@en
verifiedrevid
443,531,339
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
3,4-Ethylenedioxy-N-methylamph ...... e effects on dopamine release.
@en
エチレンジオキシメタンフェタミン (3,4-Ethylene ...... 基づいており、より大量の投与ではより作用が強い可能性がある。
@ja
label
EDMA
@en
エチレンジオキシメタンフェタミン
@ja